Medicine

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

M. Yousuf, Saubia Fathima, Ali Alsugair, Sam J Wu, Maymona G. Abdelmagid, Shraddha P Patel, Priyansh Faldu, Rania M Abdelaziz, Clifford M. Csizmar, A. Mangaonkar, Cinthya J Zepeda Mendoza, Kaaren K. Reichard, D. Viswanatha, Rong He, A. Pardanani, N. Gangat, Mirinal S Patnaik, A. Tefferi

2026.4.4Blood Cancer Journal

DOI: 10.1038/s41408-026-01500-3

Abstract

Abstract is not available.

Citation format

YOUSUF, M., et al. One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: Co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. Blood Cancer Journal, 2026, 16(1).